Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin Ren

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biophysical Journal|July 2, 2022
Labeling of a mutant estrogen receptor with an Affimer in a breast cancer cell linePin Ren, Christian Tiede, Sean W Fanning, et al.
Plos One|February 6, 2014
Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinomaLi Gong, Long-Xiao Wei, Pin Ren, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 18, 2017
Orientia tsutsugamushi infection in rodents in Anhui Province of ChinaAdams Latif, Bo-Yu Liu, Zhen Chen, et al.
The New England Journal of Medicine|March 2, 2022
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term InfantsLaura L Hammitt, Ron Dagan, Yuan Yuan, et al.
Journal of Clinical Microbiology|June 27, 2022
Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE StudyAlexey Ruzin, Olivier Barraud, Li Yu, et al.
The Lancet. Infectious Diseases|April 24, 2021
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Hasan S Jafri, Jean Chastre, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biophysical Journal|July 2, 2022
Labeling of a mutant estrogen receptor with an Affimer in a breast cancer cell linePin Ren, Christian Tiede, Sean W Fanning, et al.
Plos One|February 6, 2014
Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinomaLi Gong, Long-Xiao Wei, Pin Ren, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 18, 2017
Orientia tsutsugamushi infection in rodents in Anhui Province of ChinaAdams Latif, Bo-Yu Liu, Zhen Chen, et al.
The New England Journal of Medicine|March 2, 2022
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term InfantsLaura L Hammitt, Ron Dagan, Yuan Yuan, et al.
Journal of Clinical Microbiology|June 27, 2022
Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE StudyAlexey Ruzin, Olivier Barraud, Li Yu, et al.
The Lancet. Infectious Diseases|April 24, 2021
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Hasan S Jafri, Jean Chastre, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Pageof 3